Cargando…

C-Reactive Protein in Stable Cystic Fibrosis: An Additional Indicator of Clinical Disease Activity and Risk of Future Pulmonary Exacerbations

INTRODUCTION: In stable adult cystic fibrosis (CF) patients, we assessed the role of baseline high sensitivity C-reactive protein (hs-CRP) on CF clinical variables and frequency of intravenous (IV) treated pulmonary exacerbations (PExs) 1-year post-baseline. METHODS: We recruited 51 clinically stabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matouk, Elias, Nguyen, Dao, Benedetti, Andrea, Bernier, Joanie, Gruber, James, Landry, Jennifer, Rousseau, Simon, Ahlgren, Heather G, Lands, Larry C, Wojewodka, Gabriella, Radzioch, Danuta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218840/ https://www.ncbi.nlm.nih.gov/pubmed/28066689 http://dx.doi.org/10.4172/2161-105X.1000375

Ejemplares similares

Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients
por: Wojewodka, Gabriella, et al.
Publicado: (2014)

Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients
por: Ahlgren, Heather G., et al.
Publicado: (2015)

Cystic fibrosis–adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses
por: LaFayette, Shantelle L., et al.
Publicado: (2015)

Ceramide in Cystic Fibrosis: A Potential New Target for Therapeutic Intervention
por: Wojewodka, Gabriella, et al.
Publicado: (2011)

Corticosteroid-resistant inflammatory signalling in Pseudomonas-infected bronchial cells
por: Mizutani, Mirai, et al.
Publicado: (2017)

The protective effect of fenretinide against allergic asthma
por: Kanagaratham, Cynthia, et al.
Publicado: (2010)

Fenretinide Corrects the Imbalance between Omega-6 to Omega-3 Polyunsaturated Fatty Acids and Inhibits Macrophage Inflammatory Mediators via the ERK Pathway
por: Lachance, Claude, et al.
Publicado: (2013)

High-Dose Ibuprofen in Cystic Fibrosis
por: Lands, Larry C., et al.
Publicado: (2010)

Infection prevention and control in cystic fibrosis: One size fits all?
por: Lands, Larry C.
Publicado: (2020)

Computed tomography reveals hypertrophic remodelling of the diaphragm in cystic fibrosis but not in COPD
por: Ostadan, Fatemeh, et al.
Publicado: (2023)

Rhinovirus Load Is High despite Preserved Interferon-β Response in Cystic Fibrosis Bronchial Epithelial Cells
por: Dauletbaev, Nurlan, et al.
Publicado: (2015)

Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations
por: Martin, Clémence, et al.
Publicado: (2022)

Re-opening the pediatric pulmonary function laboratory during the ongoing COVID-19 pandemic
por: Lands, Larry C.
Publicado: (2022)

The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations
por: Fodor, Anthony A., et al.
Publicado: (2012)

The Effects of the Addition of a New Airway Clearance Device to Chest Physiotherapy in Children with Cystic Fibrosis Pulmonary Exacerbations
por: Walicka-Serzysko, Katarzyna, et al.
Publicado: (2021)

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
por: Albon, Dana, et al.
Publicado: (2023)

Impact of exacerbations of cystic fibrosis on muscle strength
por: Burtin, Chris, et al.
Publicado: (2013)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
por: Boikos, Constantina, et al.
Publicado: (2016)

Lack of CFTR in Skeletal Muscle Predisposes to Muscle Wasting and Diaphragm Muscle Pump Failure in Cystic Fibrosis Mice
por: Divangahi, Maziar, et al.
Publicado: (2009)

Acute kidney injury in stable COPD and at exacerbation
por: Barakat, MF, et al.
Publicado: (2015)

The inflammasome pathway in stable COPD and acute exacerbations
por: Faner, Rosa, et al.
Publicado: (2016)

Gene-Metabolite Expression in Blood Can Discriminate Allergen-Induced Isolated Early from Dual Asthmatic Responses
por: Singh, Amrit, et al.
Publicado: (2013)

Rhinovirus C and Respiratory Exacerbations in Children with Cystic Fibrosis
por: de Almeida, Marina B., et al.
Publicado: (2010)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
por: Wojsyk-Banaszak, I., et al.
Publicado: (2019)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Hassanzad, Maryam, et al.
Publicado: (2021)

Clinical Relevance of KRAS in Human Cancers
por: Jančík, Sylwia, et al.
Publicado: (2010)

Editorial: Quo Vadis Lipid Mediators – Lipid Mediators Implication in Inflammation and Chronic Inflammatory Diseases
por: Radzioch, Danuta, et al.
Publicado: (2021)

LasR-deficient Pseudomonas aeruginosa variants increase airway epithelial mICAM-1 expression and enhance neutrophilic lung inflammation
por: Hennemann, Lisa C., et al.
Publicado: (2021)

Metabolic Alkalosis in Adults with Stable Cystic Fibrosis
por: Al-Ghimlas, Fahad, et al.
Publicado: (2012)

Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF)
por: Hebestreit, Helge, et al.
Publicado: (2021)

Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis
por: Girón-Moreno, Rosa Maria, et al.
Publicado: (2014)

Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations
por: Sharma, Ashutosh, et al.
Publicado: (2017)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
por: Schultz, Andre, et al.
Publicado: (2023)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Hospital versus home treatment of respiratory exacerbations in cystic fibrosis
por: Lavie, Moran, et al.
Publicado: (2011)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
por: DiMango, Emily, et al.
Publicado: (2014)

Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis
por: Rajagopala, Srinivas, et al.
Publicado: (2015)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_591kkem9rvlqkdlutc9bp547ol